切换至 "中华医学电子期刊资源库"

中华胸部外科电子杂志 ›› 2016, Vol. 03 ›› Issue (03) : 164 -169. doi: 10.3877/cma.j.issn.2095-8773.2016.03.08

所属专题: 文献

论著

鲁西冀南地区低剂量螺旋CT在肺癌筛查中的应用
解耀锃1,(), 霍晓恺2, 鲁强1, 李吉臣1   
  1. 1. 252600 山东临清,聊城市第二人民医院CT室
    2. 252600 山东临清,聊城市第二人民医院超声科
  • 收稿日期:2016-05-20 出版日期:2016-08-28
  • 通信作者: 解耀锃

Clinical application of low-dose spiral CT screening for lung cancer in western Shandong and southern Hebei

Yaozeng Xie1,(), Xiaokai Huo2, Qiang Lu1, Jichen Li1   

  1. 1. Department of CT, the Second People’s Hospital of Liaocheng, Linqing 252600, China
    2. Department of Ultrasound, the Second People’s Hospital of Liaocheng, Linqing 252600, China
  • Received:2016-05-20 Published:2016-08-28
  • Corresponding author: Yaozeng Xie
  • About author:
    Corresponding author: Xie Yaozeng, Email:
引用本文:

解耀锃, 霍晓恺, 鲁强, 李吉臣. 鲁西冀南地区低剂量螺旋CT在肺癌筛查中的应用[J]. 中华胸部外科电子杂志, 2016, 03(03): 164-169.

Yaozeng Xie, Xiaokai Huo, Qiang Lu, Jichen Li. Clinical application of low-dose spiral CT screening for lung cancer in western Shandong and southern Hebei[J]. Chinese Journal of Thoracic Surgery(Electronic Edition), 2016, 03(03): 164-169.

目的

探讨鲁西冀南地区低剂量螺旋CT(LDCT)在不同性别和年龄人群中肺癌检出率的差异,为制定更适宜的筛查方案提供依据。

方法

回顾性分析2015年在聊城市第二人民医院进行LDCT肺癌筛查的2 056例受检者的资料。根据性别、国内肺癌高危人群年龄段,以及实际检出高危人群年龄段三种方法进行分组,比较各组间肺癌检出率的差异。

结果

2 056例受检者中,确诊肺癌22例,其中腺癌20例,鳞癌2例。45~75岁共检出肺癌21例,占总检出人数的95.5%(21/22)。男性组肺癌检出率为0.8%(10/1 217),女性组为1.4%(12/839),两组比较差异无统计学意义(χ2=1.738,P=0.187)。根据国内肺癌高危人群定义中的年龄段分组,高危组(50~75岁)肺癌检出率为1.3%(15/1 158),低危组(<50岁或>75岁)为0.8%(7/898),两组比较差异无统计学意义(χ2=1.271,P=0.26)。根据实际检出高危人群的年龄段分组,新高危组(45~75岁)肺癌检出率为1.4%(21/1 502),新低危组(<45岁或>75岁)为0.2%(1/554),新高危组检出率显著高于新低危组(χ2=5.668,P=0.017)。

结论

鲁西冀南地区人群在LDCT肺癌筛查中,不仅要关注男性,也要关注女性;且将肺癌筛查高危人群年龄调整为45~75岁更为合适。

Objective

To investigate the differences in lung cancer detection rates with low-dose spiral CT(LDCT) among people with different genders and ages in western Shandong and southern Hebei, and provide evidence for making better screening programs.

Methods

The clinical data of 2 056 cases undergoing lung cancer screening with LDCT in Liaocheng Second People’s Hospital in 2015 were retrospectively analyzed. Patients were divided into groups by gender, by age based on expert consensus of high-risk population of lung cancer and by age according to the actual findings of high-risk population of lung cancer, respectively, and the lung cancer detection rates were compared between groups, respectively.

Results

Twenty-two of these 2 056 cases were confirmed as lung cancer, among whom 20 were adenocarcinoma and the other 2 were squamous cell carcinoma. Twenty-one(95.5%) cases with lung cancer aged between 45 and 75 years. The lung cancer detection rates of males and females were 0.8%(10/1 217) and 1.4%(12/839), respectively, and there was no significant difference between them(χ2=1.738, P=0.187). Based on expert consensus of high-risk population of lung cancer, the lung cancer detection rates of high-risk group(50-75 years old) and low-risk group(<50 years or >75 years) were 1.3%(15/1 158) and 0.8%(7/898), respectively, and there was no significant difference between them(χ2=1.271, P=0.26). According to the actual findings of high-risk population of lung cancer, the lung cancer detection rates of new high-risk group(45-75 years old) and new low-risk group(<45 years or >75 years) were 1.4%(21/1 502) and 0.2%(1/554), respectively, and there were significant differences between them (χ2=5.668, P=0.017).

Conclusions

Attention should be paid to lung cancer screening with LDCT both in males and females in western Shandong and southern Hebei, and the age of high-risk population of lung cancer is well to be defined as 45-75 years.

表1 不同年龄段总人数与肺癌检出数(例)
表2 按性别分组肺癌检出率比较[例,%]
表3 按原高危人群年龄分组肺癌检出率比较
表4 按新高危人群年龄分组肺癌检出率比较
[1]
陈万青,郑荣寿,张思维等. 2012年中国恶性肿瘤发病和死亡分析[J].中国肿瘤,2016,25(1):1-8.
[2]
EttingerDS. Ten years of progress in non-small cell lungcancer[J]. J Natl Compr Canc Netw, 2012,10(3):292-295.
[3]
Gloeckler RiesLA,ReichmanME,LewisDR, et al. Cancersurvival and incidence from the Surveillance, Epidemiology,and End Results(SEER)program[J].Oncologist, 2003, 8(6):541-552.
[4]
HowladerN, NooneAM, KrapchoM, et al. SEER Cancer Statistics Review, 1975-2009(Vintage 2009 Populations)based on November 2011 SEER data submission[DB/OL].Bethesda(MD):National Cancer Institute,2012.
[5]
张国桢,郑向鹏,李铭.微小肺癌——影像诊断与应对策略[M].北京:人民军医出版社,2015.
[6]
周莹,刘士远等,李琼,等. 临床IA期周围型肺腺癌病理性脉管浸润与其薄层CT征象的相关性研究[J].中华放射学杂志,2015,49(4):259-263.
[7]
TravisWD,BrambillaE,NoguchiM,et al. Internationalassociation for the study of lung cancer/american thoracicsociety/european respiratory society international multidisciplinary classification of lung adenocarcinoma[J].J Thorac Oncol.201 1,6(2):244-285.
[8]
中华医学会放射学分会心胸学组. 低剂量螺旋CT肺癌筛查专家共识[J]. 中华放射学杂志,2015,49(5): 328-335.
[9]
HenschkeCI,McCauleyDI,YankelevitzDF, et al. Early Lung Cancer Action Project: overall design and findings frombaseline screening[J].Lancet, 1999, 354(9173):99-105.
[10]
HenschkeCI,BoffettaP,GorlovaO, et al. Assessment of lung-cancer mortality reduction from CT screening[J]. LungCancer, 2011,71(3): 328-332.
[11]
AbedeDR,AdamsAM,BergCD, et al. Reduced lung—cancer mortality with low dose computed tomographic screening[J].N Ensl J Med,2011,365(5):395-409.
[12]
van KlaverenRJ,OudkerkM,ProkopM, et a1. Management of lung nodules detected by volume CT scanning[J]. N Engl J Med, 2009, 361(23):2221-2229.
[13]
唐威,吴宁等,黄遥,等. 4690例无症状健康体检者低剂量CT早期肺癌筛查研究[J]. 中华肿瘤杂志,2014,36(7):549-554.
[14]
吴宁,赵世俊.积极规范地开展低剂量螺旋CT肺癌筛查[J]. 中华放射学杂志,2015,49(5): 321-322.
[15]
张春芳,曾强,王维民,等. 体检人群肺癌筛查低剂量螺旋CT检出率与成本分析[J]. 中华肿瘤防治杂志,2015,22(4): 247-251.
[1] 旺久, 陈军, 朱霞, 米玛央金, 赵胜, 陈欣林, 李建华, 王双. 山南市妇幼保健院开展胎儿系统超声筛查的效果分析[J]. 中华医学超声杂志(电子版), 2023, 20(07): 728-733.
[2] 危玲, 李会, 陈奕. 孕产妇产超广谱β-内酰胺酶的肠杆菌定植/感染与母婴传播研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 517-521.
[3] 李晓阳, 刘柏隆, 周祥福. 大数据及人工智能对女性盆底功能障碍性疾病的诊断及风险预测[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 549-552.
[4] 李小娟, 李炜佳, 彭凌燕, 周鹏莹, 李桂娥, 刘相辰. 体检人群中前列腺钙化灶的检出率及临床特征分析[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 336-338.
[5] 梁开地, 缑文斌, 莫居容. 肺癌组织中细胞角蛋白18的表达及与预后的相关性[J]. 中华肺部疾病杂志(电子版), 2023, 16(05): 688-690.
[6] 黄承路, 廖飞, 刘显平, 王志强. 血清外泌体Has_circ_0060937过度表达与NSCLC转移和不良预后的关系[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 490-494.
[7] 陈坤, 何傅梅, 方婷, 陈文瑞. 血清sCD73与EGFR/ALK野生型非小细胞肺癌免疫治疗效果的相关性分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 504-507.
[8] 朱超男, 王帅, 王文博, 郑贸根, 程远, 陈志全. 非小细胞肺癌患者组织miR-31-5p表达与临床病理特征及预后的关系[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 508-510.
[9] 徐天亮, 程干思, 吴亚平, 龚荣, 胡洁, 段群娣, 李承慧. 奥希替尼联合安罗替尼二线治疗转移性NSCLC的疗效分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 520-522.
[10] 孙文琦, 吴欣荣, 王运荣, 赵贝, 窦晓坛, 李雯, 邹晓平, 王雷, 陈敏. 结直肠上皮细胞ROS及FH检测对结直肠癌筛查的应用价值[J]. 中华结直肠疾病电子杂志, 2023, 12(04): 326-330.
[11] 鄂一民, 孙司正, 范小彧, 喻春钊. 结直肠癌粪便筛查的现状与展望[J]. 中华结直肠疾病电子杂志, 2023, 12(04): 331-336.
[12] 李京珂, 张妍春, 武佳懿, 任秀瑜. 深度学习在糖尿病视网膜病变筛查、评级及管理中的研究进展[J]. 中华眼科医学杂志(电子版), 2023, 13(04): 241-246.
[13] 刘平娟, 罗科城, 吴家茵, 廖康, 胡雯雯, 陈怡丽. 神经内科重症监护室患者肠道耐碳青霉烯类肠杆菌目细菌主动筛查研究[J]. 中华临床实验室管理电子杂志, 2023, 11(04): 235-240.
[14] 陈立如, 刘亮, 彭雷, 徐全, 章晔. 单孔胸腔镜左肺下叶袖式切除术:新辅助免疫化疗后手术[J]. 中华胸部外科电子杂志, 2023, 10(04): 228-233.
[15] 熊亚琼, 田文泽, 冷雪春, 尤振兵, 韦欣琪. 集束化干预在肺癌术后顽固性咳嗽中的应用[J]. 中华胸部外科电子杂志, 2023, 10(04): 207-212.
阅读次数
全文


摘要